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A B S T R A C T
Introduction: For the relative quantiﬁcation of isoform expression, RT-qPCR has been the gold standard for over
a decade. More recently, digital PCR is becoming widely implemented, as it is promised to be more accurate,
sensitive and less aﬀected by inhibitors, without the need for standard curves. In this study we evaluated RT-
qPCR versus RT-droplet digital PCR (ddPCR) for the relative quantiﬁcation of isoforms in controls and carriers of
the splice site mutation BRCA1 c.212+3A>G, associated with increased expression of several isoforms.
Materials and methods: RNA was extracted from EBV cell lines of controls and heterozygous BRCA1
c.212+3A>G carriers. Transcript-speciﬁc plasmids were available to determine the eﬃciency, precision, re-
producibility and accuracy of each method.
Results: Both ddPCR and RT-qPCR were able to accurately quantify all targets and showed the same LOB, LOD
and LOQ; also precision and reproducibility were similar. Both techniques have the same dynamic range and
linearity at biologically relevant template concentrations. However, a signiﬁcantly higher cost and workload was
required for ddPCR experiments.
Conclusions: Our study recognizes the potential and validity of digital PCR but shows the value of a highly
optimized qPCR for the relative quantiﬁcation of isoforms. Cost eﬃciency and simplicity turned out to be better
for RT-qPCR.
1. Introduction
In modern day genetics the concept of alternative splicing is fre-
quently investigated. Alternative splicing is a naturally occurring me-
chanism that increases the protein coding complexity of the genome.
With the formation of several transcripts from one locus the number of
proteins that can be formed out of the 20,000 genes, which make out
the human protein coding genome, increases tremendously [1]. Besides
naturally occurring alternative splicing, alternative (aberrant) tran-
scripts can also arise from mutations in the genome leading to the
formation of new splice sites or the removal of existing ones [2,3].
However, the interpretation of variants modifying alternative transcript
ratios in combination with the induction of novel transcripts is less
straightforward. Therefore, a ﬁrst step towards understanding the pa-
thogenicity of a variant, suspected to alter splicing, is accurate
quantiﬁcation of the naturally occurring transcripts together with the
discovery and quantiﬁcation of aberrant transcripts induced by the
variant. In case of suﬃcient expression of normal, functional tran-
scripts, the phenotypic eﬀect of the deleterious variant might be
minimal, because the remaining level of the normal transcript can
maintain protein functionality [3].
For transcript-speciﬁc quantiﬁcation of RNA RT-qPCR has been the
gold standard for several years [4,5]. Here, quantiﬁcation with inter-
calating dyes is the simplest and most cost eﬃcient solution, although
this method is prone to detection of non-speciﬁc ampliﬁcation, because
the dye can intercalate non-speciﬁcally (in amplicons not of interest).
Non-speciﬁc ampliﬁcation is expected to be less of a problem when
using isoform-speciﬁc hydrolysis probes. Here ﬂuorescence is only
measured when the probe can anneal to a speciﬁc target and subse-
quently gets cleaved during elongation. Accurate quantiﬁcation of all
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targets can however be impaired if one or more transcripts are sig-
niﬁcantly overrepresented in the sample [5] and the design of the
probes in a transcript-speciﬁc sequence may not always be feasible for
each isoform in combination with the design of transcript-speciﬁc pri-
mers. This and the added cost of ﬂuorescently labelled probes, are the
major limitations for qPCR with probes. Theoretically the number of
target amplicons doubles every cycle during a PCR reaction, making it
possible to perform relative quantiﬁcations (by calculating relative
diﬀerences in ampliﬁcation of target between two samples or between
targets in a single sample) or absolute quantiﬁcations (by calculating
the absolute amount of target based on a standard curve of known
quantities). To be able to compare quantities between samples, typi-
cally several stable reference genes are measured in parallel with the
expression of the target for normalization [6,7].
Recently, droplet digital PCR (ddPCR) is becoming a widely used
alternative to qPCR for the quantiﬁcation of nucleic acids in speciﬁc
applications such as copy number quantiﬁcation [8]. In ddPCR thou-
sands of nanoliter scale droplets are generated, each containing none,
one or a handful of target molecules. During PCR, each of these droplets
acts as a separate reaction volume, amplifying the target. After ampli-
ﬁcation, each droplet is read out individually and droplets with a higher
ﬂuorescence than the threshold are deemed positive. Using Poisson
distribution statistics, it is possible to estimate the starting concentra-
tion of target in each sample, allowing for both relative and absolute
quantiﬁcation at the same time without the need for a standard curve
[9]. Therefore, at ﬁrst sight, the calculation of target concentration is
simpler with ddPCR than with qPCR and accuracy of quantiﬁcation is
not dependent on the accuracy of a standard curve. However, de-
termining the threshold position for ambiguous droplets is a matter of
debate and has an impact on the accurate quantiﬁcation of the target.
New ways to tackle this problem have been proposed [10,11]. Most
recently, a data-driven method was developed, that allows for threshold
calculation using extreme value theory. According to Trypsteen et al.
[12] this method is more accurate than its predecessors because it
imposes no assumptions on the distribution of the data and it corrects
for the baseline shift between no-template-controls (NTCs) and samples.
Using an appropriate method for data analysis, ddPCR is potentially
more precise than qPCR [10,13].
The introduction of digital PCR raises the question if qPCR should
remain the gold standard for quantifying alternative transcripts. Here,
we make a comparison between qPCR and ddPCR for the relative
quantiﬁcation of such transcripts. Hereto, we use a deleterious BRCA1
mutation (c.212+3A>G) as a model for the evaluation of qPCR and
ddPCR-based quantiﬁcation. BRCA1 c.212+3A>G is a Belgian
founder mutation associated with an increased risk for breast and
ovarian cancer [14,15]. The variant was shown to induce a shift in the
ratio of naturally occurring isoforms. Three naturally occurring tran-
scripts were identiﬁed at this locus. An isoform containing the full-
length exon 5 (BRCA1-ex5FL; r.135_212), a transcript with a total skip
of exon 5 (BRCA1-Δex5; r.135_212del) and a transcript where the last
22 nucleotides of exon 5 are deleted (BRCA1-Δ22ntex5; r.190_212del)
[16]. Several other publications conﬁrmed the expression of these
isoforms in relation to this variant [17,18]. ddPCR was evaluated in
comparison to qPCR in terms of accuracy, linearity, dynamic range,
precision and reproducibility for the quantiﬁcation of transcript iso-
forms.
2. Methods and materials
2.1. Samples
For this study Epstein-Barr Virus (EBV) immortalized B cell lines
derived from individuals with a germline BRCA1 c.212+3A>G mu-
tation were used as carrier samples. For the control samples EBV cell
lines were used from individuals not carrying a germline BRCA1/2
mutation as determined by screening the entire coding region of both
genes. In total 6 carrier and 4 control samples were used. EBV cell lines
were made according to Hui-Yuen et al. [19]. Approval for generation
and usage of the EBV cell lines for fundamental research purposes was
granted by the Gent University Hospital Ethical Committee and by the
individuals whom these cell lines were derived from in the form of an
informed consent. All experiments were done in accordance with the
recommendations and restrictions set by the Gent University Hospital
Ethical Committee in compliance with the WMA declaration of Helsinki
regarding medical research on human subjects.
No nonsense mediated decay inhibitors were added to the cell cul-
tures only stable transcripts were of interest in this study. For RNA
extraction 1.5 × 106 cells were pelleted and resuspended in 3 mL cul-
ture medium (RPMI medium 1640, foetal bovine serum 10%, sodium
pyruvate 1.11%, β-mercaptoethanol 0.11%, interleukin 2 0.11%, glu-
tamine 1% and penicillin-streptomycin 0.5%; Thermo Fisher Scientiﬁc,
Waltham, USA). Cells were counted using a Bürker counting chamber.
From 1 mL RNA was extracted right away (0 h samples). 1 mL was left
in culture for another 4 h (4 h samples) and another 1 mL for 24 h (24 h
samples) before starting RNA extraction. RNA extraction was done
using RNeasy mini kit (Qiagen, Hilden, Germany) according to manu-
facturer’s protocol (without the optional DNase treatment), after which
RNA was measured on DropSense96 (Trinean, Gentbrugge, Belgium)
and stored at−80 °C. Removal of contaminating gDNA was done prior
to RT with Heat & Run DNA removal (ArticZymes, Tromsø, Norway)
following the manufacturer’s instructions. For RT, the iScript cDNA
Synthesis Kit (Bio-Rad, Temse, Belgium) was used in compliance with
the manufacturer’s recommendations. DNase treatment and RT were
done as consecutive steps on the same batch of 1 μg of total RNA.
A number of dilution series were constructed. Dilutions were made
from either EBV derived samples (controls or BRCA1 c.212+3A>G
carriers) or transcript-speciﬁc plasmids. In total 11 dilution points were
made and a no template control. 5 ng/μL yeast tRNA carrier used in all
dilutions. Plasmid series were diluted 1/10, EBV series 1 in 2. Template
concentration in all dilution points was calculated from DropSense96
measurements of the undiluted sample. A 424 bp amplicon (spanning
exons 2–7 of BRCA1) was ampliﬁed using cDNA from a patient het-
erozygous for BRCA1 c.212+3A>G as described before [16]. This
amplicon was cloned in a pCR2.1-TOPO vector (Invitrogen, Carlsbad,
USA). Individual clones were investigated through Sanger sequencing;
three clones were retained, each containing one of the three transcripts
under investigation. In all experiments these plasmids were used as
circular molecules without enzymatic linearization.
2.2. Quality control
For both qPCR and ddPCR the same primer sets were used.
Speciﬁcity of primers for all three assays was veriﬁed with qPCR on
plasmid constructs, each containing a speciﬁc isoform (Supplementary
Data A). Furthermore, speciﬁcity was also investigated for each in-
dividual qPCR reaction with melting curve analysis. All reactions con-
tained only one detectable ampliﬁcation product.
Quality control (QC) on cDNA and original RNA samples was done
via qPCR using an artiﬁcial SPUD assay [20], an exon-spanning assay
from exon 2–4 in MKNK2 (reference sequence NM_199054), which
doesn’t yield a product on gDNA as the involved introns have a com-
bined length of> 4 kb, (160 bp, F: 5′-CCAGCCGAACTTCAGGGTTT-3′,
R: 5′-CGTCCGGGATGTCAATGGG-3′; forward primer sequence in exon
2, reverse primer sequence in exon 4) and an intronic assay located
between exon 30 and 31 in ABCA4 (bp, F: 5′-CCAAGCCTACCTACAT-
GGTGT-3′, R: 5′-AGGGATCCCAAAAGAAGGAC-3′; both primers are
entirely located within the same intron; reference sequence
NM_000350). Ampliﬁcation as described in the qPCR section.
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2.3. Discovery of all relevant alternative isoforms
For the identiﬁcation of alternative splicing transcripts at the region
of interest a targeted next generation sequencing approach was devised.
Primers (F: 5′-CTCCACAAAGTGTGACCACA-3′, R: 5′-
CGGTTTCTGTAGCCCATACT-3′) spanning exons 3–7 of the BRCA1 gene
were designed to pick up all isoforms in this region. Numbering of the
nucleotides and exons according to reference sequence NM_007294.3.
cDNA from all controls or carriers was pooled together in two separate
pools. These pools provided the input material (10 ng, total RNA
equivalents) for discovery of relevant isoforms. After PCR ampliﬁcation
(see qPCR section for details) for 32 cycles on a regular thermocycler,
sequencing libraries were constructed using NEXTﬂex PCR-free DNA
Sequencing (Illumina compatible, BiooScientiﬁc, Austin, USA) with a
customization of the size selection range, exclusion of fragmentation
and an additional ampliﬁcation of the adapter-ligated library (10 cy-
cles). The quality of each library was evaluated on Bioanalyzer (High
Sensitivity DNA, Agilent, Santa Clara, USA) and quantiﬁcation of li-
braries was done using KAPA Library Quantiﬁcation Kit
(KapaBiosystems, Wilmington, USA). Finally sequencing was done on a
MiSeq (Illumina, San Diego, USA) instrument, yielding 150 bp bidir-
ectional reads. Reads were mapped to the hg19 reference genome using
TopHat2 (default settings). The sashimi plot function (MISO) integrated
in IGV was used to visualise and count the splice junctions present in
the gene of interest. RNA integrity was not explicitely investigated,
because of the small genomic region under investigation and the small
size of the amplicons of interest. The success of this targeted RNA se-
quencing approach indicates that the RNA integrity is suﬃcient for the
planned PCR experiments.
2.4. qPCR experiments
qPCR reactions were executed using SsoAdvanced universal SYBR
Green supermix (Bio-Rad) in 5 μL reactions in a 384-well format, con-
taining 10 ng cDNA (total RNA equivalents) or variable amount for di-
lution series and 500 nM primer (SPUD template 0.5 pM). Ampliﬁcation
of the target was carried out on LC480 (Roche, Basel, Switzerland), after
which melting curve analysis was done of the reaction products on the
same machine. Denaturation for 2 min at 95 °C was followed by 45 cycles
with 5 s at 95 °C, 60 °C for 30 s and 72 °C for 1 s. For melting curve
analysis, temperature increased steadily to 95 °C. All synthetic nucleic
acid oligomers in this study were synthesized by IDT (Coralville, USA)
and checked for speciﬁcity at the design stage by primer-BLAST [21] and
secondary structures using Mfold [22]. No isoform-speciﬁc probes were
used in any of the qPCR reactions. In total three isoform-speciﬁc primer
sets were used to assess the relative quantiﬁcation of all three isoforms in
each sample: BRCA1-ex5FL (81 bp, F:5′-CATGCTGAAACTTCTCAACCA-
GAA-3′, R:5′-CTTACTATATTGGTTTTCCTCGGATGT-3′), BRCA1-Δex5
(100 bp, F:5′-GCAGAAAATCTTAGAGTGTCCCATCT-3′, R:5′-AAACGTTC-
TCGGATGTTCTTTC ATGC-3′) and BRCA1-Δ22ntex5 (74 bp, F:5′-CATG-
CTGAAACTTCTCAACCAGA-3′, R:5′-AATACTCGGATGTTCTTTCATGCT-
CTAA-3′).
For the calculation of relative expression values (REijl), raw Cq va-
lues were ﬁrst transformed to relative quantities (RQijl) similar to
Hellemans et al. [23]. An average Cq (Cqijl) was calculated from the raw
Cq values of all m replicates (k) of a sample/assay combination (i/j) on
a qPCR plate (l). From here RQijl were calculated by transforming the
diﬀerence, named △Cqijl, between each Cqijl and the average Cq over
all assays (Cqil) using the assay speciﬁc PCR eﬃciency (Ej). All assays
showed eﬃciency of nearly 100%, as determined in advance in ac-
cordance with Hellemans et al. [23]. The RQijlfor each sample/assay
combination was used to determine the relative expression (REijl) of the
target to the sum of BRCA1 expression.
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2.5. Droplet digital PCR experiments
All ddPCR reactions were executed according to an optimized and
standardized protocol and contained isoform-speciﬁc primers and hydro-
lysis probes for one of the BRCA1 isoforms and RPP30 reference target.
Prior to this study the optimal annealing temperature was investigated for
every primer-probe combination. BRCA1 primers were the same as for
qPCR. BRCA1 probes were labelled with 6-FAM (BRCA1-ex5FL: 5′-/56-
FAM/AAAGGGCCT/ZEN/TCACAGTGTCCTTTATGTAA/3IABkFQ/-3′,
BRCA1-Δex5: 5′-/56-FAM/AGTTGATCA/ZEN/AGGAACCTGTCTCCA-
CAAAGT/3IABkFQ/-3′ and BRCA1-Δ22ntex5: 5-/56-FAM/AGAAAGGGC/
ZEN/CTTCACAGTGTCCT/3IABkFQ/-3′), while the RPP30 probe was HEX
labelled (F: 5′-GATTTGGACCTGCGAGCG-3′, probe: 5′-/5HEX/
TCTGACCTG/ZEN/AAGGCTCTGCGCG/3IABkFQ/-3′, R: 5′-GCGG-
CTGTCTCCACAAGT- 3′). On average 14,728 accepted droplets (range
11,842–17,227) were generated (QX100 Droplet Generator, Bio-Rad) from
20 μL mixtures containing 5 ng (or variable amount for dilution series) of
cDNA (total RNA equivalents), 250 nM primers, 900 nM probes and 10 μL
ddPCR Supermix for Probes (Bio-Rad) and were read out with a QX100
Droplet Reader (Bio-Rad). Mean copies per partition (λ) were dependent
on sample-assay combinations, with an average over all ddPCR reactions
of 2.35e-2, calculated using positive partitions as described. [24]
The PCR reaction was executed using a regular thermocycler with a
10 min denaturation step at 95 °C followed by repeated cycles con-
sisting of 15 s at 95 °C and one min at 60 °C. After 40 cycles the pro-
ducts were heated to 98 °C for 10 min before cooling to room tem-
perature.
Calling of positive and negative droplets and calculation of the
target-concentration was done by Quantasoft software (Bio-Rad) and
ddpcRquant webtool (http://www.ddpcrquant.ugent.be) [12]. Nor-
malized concentration values (NCijl) were obtained by dividing the
average concentration of m replicates (k) for a particular sample/assay
combination (Cijl) with average concentration of the corresponding
RPP30 measurements. REijl for all targets in a sample were calculated
relative to the total expression of BRCA1 in the sample.
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2.6. Statistical analysis
Data analysis, generation of ﬁgures and calculation of statistics for
qPCR and ddPCR data was executed in the R language and environment
for statistical computing [25]. Statistical signiﬁcance for the compar-
ison of controls and carriers tested by the Mann-Whitney test, while
qPCR and ddPCR results were compared using the Wilcoxon signed-
rank test. We adopted α= 0.001, making sure that we only claim there
is a diﬀerence between the compared results with a very small margin
of error. Coeﬃcients of variation were calculated for each EBV cell line
as the standard deviation between measurements of a cell line over all
time points divided by the mean of these measurements. LOB, LOD and
LOQ were deﬁned based on Armbruster and Pry. [26]
3. Results
3.1. Quality control on RNA and cDNA samples
Total RNA was obtained from Epstein Barr Virus (EBV) cell lines,
derived from both control individuals and BRCA1 c.212+3A>G car-
riers, and treated with HL-dsDNase to remove remaining genomic DNA
(gDNA) before reverse transcription (RT) and quality control. Cells
were harvested at three time points: right after (0 h), 4 h and 24 h after
culture medium renewal. gDNA contamination was detected in all in-
itial total RNA extracts by an intronic assay, no gDNA was measured in
any sample after RT, proving the eﬃciency of the HL-dsDNase treat-
ment. An exon-spanning assay (not allowing ampliﬁcation on gDNA)
showed no ampliﬁcation on RNA samples before RT and clear ampli-
ﬁcation on cDNA samples, implying that RT was successfully executed.
Finally all samples showed highly similar ampliﬁcation with the SPUD
assay [20], so it was concluded that none of the samples showed ele-
vated inhibition compared to any of the other samples. Data of all
quality control measures can be seen in Supplementary data B.
3.2. Discovery of transcript variants in the BRCA1 c.212+3A>G model
For the relative quantiﬁcation of isoforms within samples, it is im-
portant to have an understanding of all (stably) expressed transcripts.
Earlier reports [16–18] described three isoforms of interest around exon
5 in BRCA1 c.212+3A>G carriers: BRCA1-ex5FL (r.135_212), BRCA1-
Δex5 (r.135_212del) and BRCA1-Δ22ntex5 (r.190_212del). Here we
veriﬁed these using a PCR-based targeted deep sequencing approach,
which has never been done before for patient samples with this variant.
Fig. 1 summarizes the results of this experiment and visualises them as a
sashimi plot.
3.3. Relative quantiﬁcation of BRCA1 c.212+3A>G transcript variants
by qPCR and ddPCR
3.3.1. Eﬃciency
For both qPCR and ddPCR we investigated besides linearity and
dynamic range, also limit of blank (LOB), limit of detection (LOD), and
limit of quantiﬁcation (LOQ) [26]. These metrics were evaluated using
target quantiﬁcations with both methods on dilution series and the data
are depicted in Fig. 2.
RPP30, the internal reference target for ddPCR, was also found to
have a wide dynamic range, excellent linearity within this range and a
LOQ similar to BRCA1-ex5FL in all EBV derived samples as can be seen
in Supplementary Data C.
3.3.2. Precision and reproducibility
The variation in relative expression for each isoform over all time
points of extraction was studied by calculating the coeﬃcient of var-
iation (CV). Boxplots of these CVs, for all isoforms in both sample
groups using both techniques, are depicted in Fig. 3.
3.3.3. Accuracy
Quantiﬁcation of the expression of each isoform relative to the sum
of all three isoforms is shown in Fig. 4. In BRCA1 c.212+3A>G mu-
tation carriers both qPCR (a) and ddPCR (b) conﬁrmed results that were
previously published [16]. There is a diminished relative abundance of
BRCA1-ex5FL caused by a statistically signiﬁcant increase of BRCA1-
Δ22ntex5 expression in carriers: a 8.84 ± 1.78 fold increase in relative
abundance was measured using qPCR, whereas ddPCR showed a
6.97 ± 0.75 increase (p = 1.16e-8 for both techniques, mean of all
three time points). The impact of BRCA1 c.212+3A>G on the BRCA1-
Δex5 isoform is less drastic. For BRCA1-Δex5 a 1.95 ± 0.128 fold
change is seen with qPCR and a 1.56 ± 0.32 diﬀerence with ddPCR
(p = 2.31e-8 and 6.14e-5 respectively, mean of all three time points).
In a correlation plot (Supplementary D, left side panel) we evaluated
the correlation between qPCR versus ddPCR results obtained for each
isoform relative to the sum of all isoforms, as an estimate of total
BRCA1 expression. This graph indicates that there is a small but sys-
tematic diﬀerence in measurement of the expression as the data are
situated primarily on one site of the diagonal. In Supplementary D
(right side panel) a Bland-Altman plot clariﬁes the extent of the dif-
ference. This shows that the discrepancy between both methods is
small, but clusters to one side of the mean and a perfect agreement
between methods cannot be concluded. In control samples (depicted by
black data points) the data are almost entirely located to one side of the
mean indicating a true diﬀerence between both techniques.
Underestimation of BRCA1-ex5FL will lead to an overestimation of
BRCA1-Δ22ntex5 and BRCA1-Δex5 expression levels, or vice versa, by
which the data points shift to opposite sides of the curve. There is a
statistically signiﬁcant diﬀerence between the qPCR and ddPCR results
for BRCA1-Δ22ntex5 (p = 1.89e-5) and BRCA1-ex5FL (p = 3.79e-6) in
controls. In carriers the same eﬀect is observed, although less pro-
nounced and not statistically signiﬁcant. This explains why the fold-
change of BRCA1-Δ22ntex5 expression is roughly 25% higher for qPCR.
In Supplementary data E the same analysis can be seen using
Quantasoft (Bio-Rad). Here the discrepancies between qPCR and ddPCR
data are even bigger, demonstrating the importance of an accurate way
to call positive droplets.
To further evaluate the accuracy of both methods we used artiﬁcial
mixtures, each containing a known relative amount of transcript-spe-
ciﬁc plasmid. Three such mixtures (hereafter designated as samples
1–3) were made and measured using both methods, to test if consistent
overestimation of one target leads to the consistent underestimation of
one or multiple other targets. Results of the relative quantiﬁcation of
these mixtures and their accuracy can be seen in Fig. 4(c) and (d). All
relative quantiﬁcations correlated relatively well to the theoretical re-
lative abundance. qPCR measurements were found to correlate slightly
better with the theoretical relative quantities than ddPCR. This eﬀect is
mainly explained by the overestimation of BRCA1-Δex5 leading pre-
dominately to an underestimation of BRCA1-Δ22ntex5 and BRCA1-
ex5FL or vice versa.
3.3.4. Economics
A last consideration when comparing ddPCR and qPCR is the cost,
workload and time required to perform analyses. For this study, the cost
of digital PCR experiments per reaction was a little over two times
greater than that of qPCR. We looked at the cost per reaction carried out
as described in the methods section taking into account the four-fold
diﬀerence in reaction volume. The cost to generate droplets and read
out the droplets was not taking into account. This would make the
ddPCR experiments 6 times more expensive than the qPCR approach.
The number of ddPCR reactions that could be performed in the same
timeframe was signiﬁcantly smaller than with qPCR. In one workday
three 384-well plates of qPCR reactions were possible, whereas only
two 96-well plates with ddPCR droplets could be executed.
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Fig. 1. Sashimi plot of targeted RNA sequencing results. For the relative transcript quantiﬁcation, the relative abundance of the three relevant transcripts was calculated as the number of
reads covering the transcript-speciﬁc splice site divided by the total number of reads spanning the 3 splice sites (junctions 5–7). RNA positions are based on reference sequence
NM_007294.3 starting at the A of the translation initiation codon (ATG) as position +1. Genomic positions are derived from hg19 reference sequence. 13 unique junctions were identiﬁed
in controls (depicted in orange) and/or BRCA1 c.212+3A>G carriers (grey). At the boundary between exon 6 and 7 (junction 1), 59,606 and 72,822 reads were identiﬁed for the
controls and the carriers respectively. As expected, three highly abundant transcripts are found on the other end of exon 6, connecting it to either exon 5 (junctions 5 and 6) or exon 3
(junction 7). For junction 5 (BRCA1-ex5FL), junction 6 (BRCA1-Δ22ntex5; c.191_212del22) and junction 7 (BRCA1-Δex5; c.135_212del78) the sum of the number of identiﬁed reads for
these junctions is 59,486 and 69,525, which equals 99.80% and 87.01% of the number of reads at junction 1 for controls and the carriers respectively. In carriers the 13% diﬀerence is not
explained by the novel junctions (junctions 3, 4 and 9), therefore we assume that the diﬀerence is caused by a percentage of prematurely terminated reads. The extremely low coverage
also suggests that all junctions other than 1, 5, 6, 7 and 11 are artefacts, introduced by PCR or bioinformatics, rather than relevant isoforms. In BRCA1 c.212+3A>G carriers there is
almost a ﬁve-fold relative diﬀerence in expression for BRCA1-Δ22ntex5 compared to controls, while BRCA1-Δex5 expression ratios are similar between carriers and controls.
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4. Discussion
ddPCR has gained popularity in recent years for nucleic acid
quantiﬁcation and is said to be highly accurate, sensitive and less af-
fected by inhibitors, while measuring target concentrations in a direct
manner without the need for standard curves [27]. Studies evaluating
the use of ddPCR for pathogen detection, copy number analysis and
other applications have been published and some conclude that ddPCR
has a lower LOD and is more robust than qPCR in terms of coeﬃcients
of variation and resistance to inhibition [8,27]. Yet, not all sources
deem ddPCR to be more accurate and precise than qPCR; both techni-
ques often yield similar results with a high degree of correlation [9,28].
For relative abundance of expressed transcripts and isoforms, published
data are limited to a multiplex ddPCR approach for the quantiﬁcation of
4 isoforms simultaneously. Also here the acquired expression proﬁle is
highly similar to previously reported data generated via qPCR [29]. A
multiplex ddPCR setup might not always be feasible for the quantiﬁ-
cation of multiple transcripts. Design of transcript-speciﬁc probes can
be challenging and multiple probes for a single locus have the potential
to cross-react in a multiplex reaction. Using boundary spanning probes
can also interfere with accurate quantiﬁcation of isoforms, especially in
case of a large diﬀerence in abundance between transcripts [5].
The aim of this study was to evaluate the performance of digital PCR
(dPCR), in the form of the droplet digital PCR platform, compared to
qPCR for quantiﬁcation of the relative abundance of transcript iso-
forms. We report on linearity and dynamic range, precision and re-
producibility, accuracy, cost and labour-intensity for both techniques,
using BRCA1 c.212+3A>G as a model splice site mutation.
Here qPCR assays often had a wider dynamic range, as ddPCR could
not accurately quantify the upper limit of the plasmid series and the
Fig. 2. Linearity and dynamic range was tested on for all assays with both quantitative PCR methods, using dilution series containing transcript-speciﬁc plasmids ((a) and (b)) or cDNA
from EBV samples (non-carriers ((c) and (d)) and carriers ((e) and (f)). Measured relative template quantity (RQ) is depicted on the y-axis in function of theoretical template concentration
on the x-axis. Almost all assay-sample combinations show excellent linearity with both techniques (R2 > 0.98). Linearity was only worse for BRCA1-Δex5 in dilutions from EBV controls
with ddPCR (R2 = 0.81). An important diﬀerence is that the dynamic range of qPCR across the dilution series was larger for several sample-target combinations, especially when
quantifying transcript-speciﬁc plasmids. From these data we also estimated the LOB, LOD and LOQ values. For both methods LOB was equal to 0 (none of the no template controls yielded
any ampliﬁcation) and the LOQ and LOD for both methods reaches the theoretical minimum of 1 copy per reaction in transcript-speciﬁc plasmid dilution series. When using EBV derived
samples the LOQ for both qPCR and ddPCR was found to range between 100 pg and 6.25 ng of cDNA depending on the abundance of a certain transcript in each sample.
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lower limit of the EBV derived series. It seems that at ﬁrst sight, ddPCR
is more easily saturated in some samples and less sensitive in other
samples than qPCR, contradicting what has earlier been suggested [27].
The saturation limit of ddPCR reactions is dependent on the number of
droplets. The maximal theoretical number of plasmid molecules that
could be detected by our ddPCR setup was 15,000 molecules. With an
average number of partitions of 14,728 in this study, the ratio of the
most concentrated plasmid dilution point that was eﬃciently quantiﬁed
is approximately 1.02. All dilution samples with concentrations>
15,000 template molecules contained at least 10 x the amount of mo-
lecules, demonstrating ddPCR’s inability to quantify samples with a
large template to partition ratio. For optimal precision, dPCR is best
used at template to partition ratio of 1.59. [24] It is however highly
unlikely that biological samples will contain such numbers. In EBV
carrier samples all three assays seem to have lower LOD values with
qPCR, but in EBV control series ddPCR seems to outperform qPCR for
BRCA1-Δ22ntex5 and BRCA1-Δex5 and in plasmid dilutions the LOQ
for both techniques is situated at the theoretical minimum. With these
discrepancies we should take into account the low amounts of total
cDNA that is used as input in these low regions of the EBV series and
therefore stochastic eﬀects should be considered. Our conclusion is that
ddPCR and qPCR show the same LOB, LOD and LOQ and have the same
dynamic range and linearity at biologically relevant template con-
centrations.
The variation between two RNA samples extracted from the same
culture at diﬀerent time points does not correlate between qPCR and
ddPCR, which indicated that the variation, between replicates extracted
at diﬀerent time points, is due to technical variation rather than bio-
logical. This is further supported by the fact that the magnitude of CV
values is inversely correlated to the expression level of each isoform and
that the means of these CV values do correlate between both methods.
Mestdagh et al. showed coeﬃcients of variations that range from<
10%, for RNA triplicates with Cq values between 15 and 30, till 50%
for replicates with Cq > 30 [30]. Cq values for BRCA1-Δ22ntex5 and
BRCA1-Δex5 were situated in the latter range, while BRCA1-ex5FL re-
actions were situated in the former. Therefore, the majority of the
variation is related to the stochastic eﬀect inherent with analysis of low
expression isoforms. Coeﬃcients of variation are within the same range
for both quantitative PCR methods and this holds true for all three
isoforms under investigation, therefore both methods are deemed
equally precise and reproducible.
For analysis of the ddPCR data we applied both ddpcRquant and the
standard Quantasoft software. Using ddpcRquant reduced time-of-RNA-
extraction-dependent variation, which is considered to be technical
variation, and made the relative expression levels more similar to qPCR
results, thereby enhancing the correlation between both technologies.
Standard errors also decreased when using ddpcRquant, as the variation
between technical replicates became smaller. A possible explanation
might be that Quantasoft assumes a normal distribution of the ﬂuor-
escent amplitudes or the threshold is placed too close to the negative
droplet population, both of which will result in inaccurate positive
droplet calling. The ddpcRquant algorithm stays clear of any distribu-
tion assumptions as well as accounts for shifts in baseline ﬂuorescence
[12].
Considering ddpcRquant as the analysis method of choice for ddPCR
data, relative expression values for all three isoforms yielded similar
results with both methods (Fig. 4(a) and (b)), although the correlation
and Bland-Altman plot (Supplementary Data D) show that data points
are not nicely distributed along the diagonal and the mean diﬀerence
line for all sample/assay combinations. The same holds true for the
artiﬁcially created samples, were qPCR is slightly more accurate in
quantifying the relative abundance of each transcript (Fig. 4(c) and
(d)).
Aside from these considerations, an overall better performance
cannot be concluded for either technique, considering the similarity of
the quantitative results and the fact that here we only investigated a
single splice site mutation as a model for alternative splicing. Both
methods were able to accurately quantify several targets over a range of
dilutions, showed accurate relative quantiﬁcation on both human-de-
rived samples and artiﬁcially created samples and had similar LOB,
LOD and LOQ values. Our results also show similarity between the
relative quantiﬁcation results obtained with both quantitative PCR
techniques and next generation sequencing, although it has to be noted
that the experimental design of NGS was devised for discovery purposes
and not as a validation method for relative quantiﬁcation.
Cost comparisons seem entirely application and setup-dependent as
Fig. 3. Boxplot of coeﬃcients of variation for all cDNA-assay combinations over all time points of both quantitative PCR techniques. We observed an inverse correlation between the CV
and the relative abundance of each isoform; CVs are consistently higher for isoforms with lower expression. CVs for each transcript range within the same order of magnitude and all
experiments show very small standard errors, leading us to conclude that precision, reproducibility and repeatability are not an issue with either quantitative PCR technique.
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other studies have reported both worse and better cost ratios for ddPCR
compared to qPCR [9,28]. The cost of ddPCR could go down by in-
troducing a dsDNA intercalating ﬂuorophore instead of target-speciﬁc
probes, but this would make the use of an internal reference target
(RPP30 in this case) impossible. Calculating relative expression values
with unnormalized concentrations measured by ddPCR, gave larger
standard errors as a result of more variation between replicates.
Therefore the use of at least one (possibly more) highly stable internal
reference target seems advisable. Performing ddPCR also took more
hands-on manipulations such as the addition of probes and droplet
generation/calling. Of note, the advantage of ddPCR for absolute
quantiﬁcation through direct quantiﬁcation without the need for a
standard curve is of no use when doing relative quantiﬁcation. Data-
analysis for both methods requires some ﬁnesse, as qPCR data need to
be converted to relative quantities in order to obtain linear relative
expression values and ddpcRquant requires careful consideration of
how the positive droplets are called. It should be noted that relative
abundance results, calculated in the discovery phase using NGS, are
similar to the results of both PCR methods without the need for isoform-
speciﬁc primer and/or probe design.
Based on the data collected here, ddPCR appears to be an accurate
and valid alternative to qPCR for the evaluation of the relative abun-
dance of alternative transcription. For BRCA1 c.212+3A>G carriers
and controls both techniques gave similar results, although we admit
that these results reﬂect the performance of qPCR and ddPCR on just
one splice site mutation. Although literature promises a whole new
generation of PCR, data show here that qPCR should not be cast aside
just yet, at least not for relative quantiﬁcation of splice variants, pro-
vided that a carefully optimized qPCR standard operating procedure is
used. The arrival of this next generation quantitative PCR method
should be welcomed as an addition to qPCR, rather than a replacement
of, especially for relative quantiﬁcation of gene/isoform expression.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in the
online version, at http://dx.doi.org/10.1016/j.bdq.2017.09.001.
Fig. 4. (a) and (b) show relative expression values for all relevant isoforms at all time points of extraction for qPCR and ddPCR. Data points from carrier samples and control samples are
shown in yellow and grey respectively. In accordance with the literature and our NGS data, BRCA1-Δ22ntex5 is highly overexpressed in carriers in comparison to controls. (c) and (d)
show the quantiﬁcation of sample 1, 2 and 3. Sample 1 contained 33%, 33% and 34% of plasmid containing BRCA1-Δ22ntex5, BRCA1-ex5FL and BRCA1-Δex5 respectively. For samples 2
and 3 this was 57%/28%/15% and 30%/38%/32% respectively. The theoretical relative amount of each transcript in each sample (depicted with white dots in each bar) was calculated
based on the volume of plasmid stock that was added, the measured amount of plasmid (ng/μL) in the stock solution and the theoretical molecular weight of each plasmid (based on the
plasmid sequence).
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